<DOC>
	<DOCNO>NCT01207245</DOCNO>
	<brief_summary>Cystic fibrosis common inherited life limit condition affect child . Patients develop lung infection become difficult clear , damage lung . These treat antibiotic ( tobramycin ) vein ( term `` intravenous antibiotic '' ) . This without doubt improve survival . However , treatment side effect . Tobramycin cause kidney damage . The investigator preliminary data suggest administer tobramycin morning may safer kidney administer evening . The investigator plan approach child adult cystic fibrosis whose doctor decide administer course intravenous tobramycin . The investigator randomly allocate receive either 0800h 2200h . The investigator measure rate body eliminate tobramycin bloodstream , measure amount tobramycin blood stream administer antibiotic . For patient study last duration course antibiotic . This decide doctor look patient ( rather researcher ) , would typically 14 day . The investigator also measure substance blood urine ( `` biomarkers '' ) sensitive indicator low level kidney injury . The investigator monitor lung function lung bacteria group ensure patient group improve amount . If preliminary data prove correct , research allow investigator improve safety profile tobramycin , one widely prescribe drug cystic fibrosis .</brief_summary>
	<brief_title>Circadian Rhythm In Tobramycin Elimination In Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Tobramycin</mesh_term>
	<criteria>Diagnosis cystic fibrosis ( CF ) ( define clinical feature CF plus positive sweat test OR presence 2 gene know associated CF disease ) Males female 5 year old Treating doctor decide commence course tobramycin Patient parent / legal guardian able give inform consent Previous episode acute kidney injury Solid organ transplantation Evidence impair renal function ( raise serum creatinine normal range age ) Once daily aminoglycoside unsuitable hypersensitivity previous high trough level daily dose . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Cystic fibrosis</keyword>
	<keyword>Tobramycin</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Toxicity</keyword>
</DOC>